a multicenter, retrospective study (re-enact 2) on the use of razumab (world´s first biosimilar ranibizumab) in wet age-related macular degeneratio
本文档由 163667721 分享于2020-03-19 14:10
a multicenter, retrospective study (re-enact 2) on the use of razumab (world´s first biosimilar ranibizumab) in wet age-related macular degeneratio
君，已阅读到文档的结尾了呢~~